FDA Grants CLIA Waiver To ABMC For Its Drug Test
September 1st, 2008 by 
admin American Bio Medica Corporation (NASDAQ:ABMC) declared that the US Food and Drug Administration (FDA) has acknowledged CLIA waived position to the Company’s Rapid TOX® saucer of assemblage take effort creation line. The relinquishment applies to every 14 drugs that the Company currently tests for in constituent to digit assorted cut-off levels for its Opiate and Cocaine tests. CLIA waived tests are constituted by bureau to be so ultimate to ingest and so faithful that there is lowercase venture of error.
Posted in Addiction | 